Vanguard Group Inc Clene Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Clene Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,619,703 shares of CLNN stock, worth $969,290. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,619,703
Previous 2,618,388
0.05%
Holding current value
$969,290
Previous $785,000
43.44%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CLNN
# of Institutions
54Shares Held
7.44MCall Options Held
48.1KPut Options Held
160K-
Geode Capital Management, LLC Boston, MA947KShares$350,2160.0% of portfolio
-
Lunt Capital Management, Inc. Holladay, UT513KShares$189,7590.11% of portfolio
-
Scoggin Management LP New York, NY500KShares$185,0000.08% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL474KShares$175,4280.0% of portfolio
-
Morgan Stanley New York, NY339KShares$125,2940.0% of portfolio
About Clene Inc.
- Ticker CLNN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,502,000
- Market Cap $23.5M
- Description
- Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...